Pipeline Scope Testimonials

Due to its superior data quality and ease of use, in one year Scope has taken the industry by storm. Please read some fantastic feedback we have received from our clients:

Dr. Roman Lapka Director IP, Zentiva k.s. :
“I use Pipeline Scope quite frequently for checking basic patent, SPC and data exclusivity expiry. My current experience is very positive. The database is reliable, seems to be frequently updated, well-arranged, user friendly.”

Sreeji Nair, Intellectual Property Manager – Bluefish Pharmaceuticals :
“I have been extremely impressed with Pipeline Scope. Starting right from the basics of innovator patents to the elaborate insight on country litigation, everything is just one click away. One more aspect is the availability of first marketing authorisation and data exclusivity expiries, a primary step for any Generics to file and enter the required market, a really important parameters that’s captured here. I feel GenericsWeb is a good tool for an expert as well as a fresher to rely on. I congratulate and thank them for providing such vast and precise information related to the 1400 INN they have in their database.”

Patent Search Specialist – Novartis Pharma AG:
“I think this database meets the demands of information professionals as well as of end users. The legal status data on about 1400 products are more complete and up-to-date than in many other database. Amongst the relevant data listed up, are patent expiry dates, SPC data and paediatric extension data. Furthermore the export format is very comprehensive. It gives a quick overview on a lot of different patent data just on one page.”

Head of Intellectual Property - Genepharm SA
“Scope is an exhaustive database encompassing different aspects associated with human medicine. It provides the history, geography and future of a product at the click of a button. With critical inputs like Data exclusivity, patent and SPC expiry the database improves a generic company’s perspective to opportunities available in different markets before filing the generic application. Additional information like briefs of patent litigation in the respective jurisdiction also provide an indication of the strength of a patent.”

Marketing and Business Development Director - Focus Pharmaceuticals
"I have found Scope very easy to use and great reference tool. The addition of information on legal challenges on molecules has also been of benefit, and has saved a great deal of time in trying to keep up to date with developments. For a small company with limited resources Scope has helped in the accuracy of information upon which to make decisions and done so at a reasonable cost."